Skip to main content
Premium Trial:

Request an Annual Quote

Clemson, Greenwood Genetic Center to Invest $15M in New Genetics Initiative, Facility

NEW YORK, July 22 (GenomeWeb News) - Clemson University and Greenwood Genetic Center announced this week that they have formed a partnership called the Genetics Collaborative to increase research and doctoral education in human genetics.


According to their agreement, the two South Caroloina-based institutions plan to invest nearly $15 million in the initiative, which will include the construction of a new 20,000 square-foot graduate education center on the Greenwoodcampus.


The new initiative will focus on South Carolina's level of birth disorders, which is above the national average.


"We are determined to break new ground in clinical service, laboratory and diagnostic testing, educational programs and research," said Roger Stevenson, the director of the GreenwoodGeneticCenter.


John Kelly, vice president for public service and agriculture at ClemsonUniversity, said in a statement that the initiative "will build on Clemson's expertise in plant and animal genetics and will expand our capabilities in nutrigenomics."

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.